Arcutis Biotherapeutics, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 31.43 | 4,992 | 156,906 | 871,391 | 876.4 K to 871.4 K (-0.57 %) |
| Mar 24 2021 | ARQT | Arcutis Biotherape ... | CHAUDHURI BHASKAR | Director | Sell | S | 30.77 | 5,008 | 154,115 | 876,383 | 881.4 K to 876.4 K (-0.57 %) |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 0.58 | 1,222 | 709 | 21,996 | |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 1,041 | 1,750 | 24,991 | |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Option Exercise | M | 1.68 | 390 | 655 | 10,934 | |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 0.58 | 1,222 | 709 | 208,286 | 207.1 K to 208.3 K (+0.59 %) |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 1,041 | 1,750 | 207,064 | 206 K to 207.1 K (+0.51 %) |
| Mar 18 2021 | ARQT | Arcutis Biotherape ... | Welgus Howard G. | Director | Buy | M | 1.68 | 390 | 655 | 206,023 | 205.6 K to 206 K (+0.19 %) |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 44,982 | |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 1,250 | 41,125 | 86,715 | 88 K to 86.7 K (-1.42 %) |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 500 | 16,450 | 46,321 | 46.8 K to 46.3 K (-1.07 %) |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 46,821 | 46.3 K to 46.8 K (+1.08 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 32.44 | 99,200 | 3,218,048 | 99,200 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.55 | 1,750 | 53,463 | 597,166 | 598.9 K to 597.2 K (-0.29 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 32,700 | 0 | 598,916 | 566.2 K to 598.9 K (+5.78 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 12,396 | 20,833 | 97,684 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 12,396 | 20,833 | 46,321 | 33.9 K to 46.3 K (+36.54 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,500 | 0 | 33,925 | 24.4 K to 33.9 K (+38.89 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Burnett Patrick | See Remarks | Grant | A | 0.00 | 9,500 | 0 | 9,500 | 0 to 9.5 K |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Grant | A | 0.00 | 9,500 | 0 | 31,667 | 22.2 K to 31.7 K (+42.86 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | OSBORNE DAVID W | Chief Technical Off ... | Grant | A | 0.00 | 9,500 | 0 | 246,753 | 237.3 K to 246.8 K (+4.00 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Grant | A | 0.00 | 9,500 | 0 | 18,771 | 9.3 K to 18.8 K (+102.47 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Sell | S | 34.52 | 934 | 32,242 | 9,271 | 10.2 K to 9.3 K (-9.15 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Turney Patricia A. | SVP, Operations | Sell | S | 34.52 | 934 | 32,242 | 9,271 | 10.2 K to 9.3 K (-9.15 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Lock Kenneth A. | Chief Commercial Of ... | Sell | S | 34.20 | 933 | 31,908 | 22,167 | 23.1 K to 22.2 K (-4.04 %) |